Mikko Valtanen
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mediation analysis in longitudinal intervention studies with an ordinal treatment-dependent confounder.
Journal: Statistical methods in medical research
Published: March 18, 2026
Long-term remission of impaired glucose tolerance in the finnish diabetes prevention study.
Journal: Diabetes research and clinical practice
Published: January 12, 2026
Risk and prognosis of myocardial infarction in patients with neurofibromatosis type 1: Evidence of compromised survival.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: March 17, 2025
Dentofacial Malocclusion in Neurofibromatosis 1 in Finland.
Journal: American journal of medical genetics. Part A
Published: January 16, 2025
Unraveling the Factors Associated With Digital Health Intervention Uptake: Cross-Sectional Study.
Journal: JMIR mHealth and uHealth
Published: July 02, 2024
Hospital Visits Associated With Oral Infections in Patients With Neurofibromatosis Type 1: A Register-Based Analysis.
Journal: American journal of medical genetics. Part A
Published: June 19, 2024
Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 04, 2024
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
Journal: Molecular genetics & genomic medicine
Published: June 07, 2023
Increased risk for dementia in neurofibromatosis type 1.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: April 23, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026